Works matching IS 09024441 AND DT 2025 AND VI 114 AND IP 5

Results: 21
    1

    Relapsed/Refractory Follicular Lymphoma: Current Advances and Emerging Perspectives.

    Published in:
    European Journal of Haematology, 2025, v. 114, n. 5, p. 775, doi. 10.1111/ejh.14401
    By:
    • Caridà, Giulio;
    • Martino, Enrica Antonia;
    • Bruzzese, Antonella;
    • Caracciolo, Daniele;
    • Labanca, Caterina;
    • Mendicino, Francesco;
    • Lucia, Eugenio;
    • Olivito, Virginia;
    • Rossi, Teresa;
    • Neri, Antonino;
    • Vigna, Ernesto;
    • Tassone, Pierfrancesco;
    • Tagliaferri, Pierosandro;
    • Morabito, Fortunato;
    • Gentile, Massimo
    Publication type:
    Article
    2
    3

    Avatrombopag for the Treatment of Immune Thrombocytopenia.

    Published in:
    European Journal of Haematology, 2025, v. 114, n. 5, p. 733, doi. 10.1111/ejh.14395
    By:
    • Labanca, Caterina;
    • Vigna, Ernesto;
    • Martino, Enrica Antonia;
    • Bruzzese, Antonella;
    • Mendicino, Francesco;
    • Caridà, Giulio;
    • Lucia, Eugenio;
    • Olivito, Virginia;
    • Puccio, Noemi;
    • Neri, Antonino;
    • Morabito, Fortunato;
    • Gentile, Massimo
    Publication type:
    Article
    4
    5

    Sustained Improvement in Health‐Related Quality of Life in Transplant‐Ineligible Newly Diagnosed Multiple Myeloma Treated With Daratumumab, Lenalidomide, and Dexamethasone: MAIA Final Analysis of Patient‐Reported Outcomes.

    Published in:
    European Journal of Haematology, 2025, v. 114, n. 5, p. 883, doi. 10.1111/ejh.14392
    By:
    • Perrot, Aurore;
    • Facon, Thierry;
    • Plesner, Torben;
    • Usmani, Saad Z.;
    • Kumar, Shaji;
    • Bahlis, Nizar J.;
    • Hulin, Cyrille;
    • Orlowski, Robert Z.;
    • Nahi, Hareth;
    • Mollee, Peter;
    • Ramasamy, Karthik;
    • Roussel, Murielle;
    • Jaccard, Arnaud;
    • Delforge, Michel;
    • Karlin, Lionel;
    • Arnulf, Bertrand;
    • Chari, Ajai;
    • Wang, George;
    • Gupta‐Werner, Niodita;
    • Kaila, Shuchita
    Publication type:
    Article
    6
    7

    Factors and Considerations in No‐Treatment Decisions in Patients With Key Hematological Malignancies: A Nationwide, Population‐Based Study in the Netherlands.

    Published in:
    European Journal of Haematology, 2025, v. 114, n. 5, p. 872, doi. 10.1111/ejh.14390
    By:
    • Zijlstra, Myrte;
    • Snijders, Rolf A. H.;
    • de Boer, Fransien;
    • Chamuleau, Martine E. D.;
    • Fransen, Heidi P.;
    • Oerlemans, Simone;
    • van der Padt‐Pruijsten, Annemieke;
    • Posthuma, Eduardus F. M.;
    • Visser, Otto;
    • Zweegman, Sonja;
    • Raijmakers, Natasja J. H.;
    • Dinmohamed, Avinash G.
    Publication type:
    Article
    8
    9
    10
    11
    12

    Electrophysiological Studies in Combination With Interim‐Positron Emission Tomography Scan for Prevention of Severe Brentuximab‐Vedotin‐Induced Neurotoxicity.

    Published in:
    European Journal of Haematology, 2025, v. 114, n. 5, p. 802, doi. 10.1111/ejh.14384
    By:
    • Pezzullo, Luca;
    • Piscosquito, Giuseppe;
    • Settembre, Lorenzo;
    • Avventura, Stefano;
    • Serio, Bianca;
    • De Biasi, Giuseppe;
    • Rizzo, Michela;
    • Noioso, Ciro Maria;
    • D'Addona, Matteo;
    • Landolfi, Annamaria;
    • Vinciguerra, Claudia;
    • Giudice, Valentina;
    • Barone, Paolo;
    • Selleri, Carmine
    Publication type:
    Article
    13

    Favourable Outcome of Relapsed PCNSL Among Transplant Eligble Patients.

    Published in:
    European Journal of Haematology, 2025, v. 114, n. 5, p. 840, doi. 10.1111/ejh.14382
    By:
    • Pellonperä, Eetu;
    • Puhakka, Inka;
    • Kuitunen, Hanne;
    • Rönkä, Aino;
    • Sunela, Kaisa;
    • Kuusisto, Milla E. L.;
    • Klaavuniemi, Tuula;
    • Jäkälä, Pekka;
    • Rajamäki, Aino;
    • Arkko, Ulla‐Mari;
    • Kuittinen, Outi
    Publication type:
    Article
    14
    15
    16

    Increased Non‐Relapse Mortality in Older People With Allogeneic Hematopoietic Stem Cell Transplantation Using Fludarabine and Myeloablative Dose of Busulfan‐Based Regimen.

    Published in:
    European Journal of Haematology, 2025, v. 114, n. 5, p. 852, doi. 10.1111/ejh.14374
    By:
    • Shinohara, Akihito;
    • Shindo, Michiho;
    • Nakano, Nobuaki;
    • Sakaida, Emiko;
    • Uchida, Naoyuki;
    • Fukushima, Kentaro;
    • Nakazawa, Hideyuki;
    • Serizawa, Kentaro;
    • Kanda, Yoshinobu;
    • Kawakita, Toshiro;
    • Ikeda, Takashi;
    • Ohigashi, Hiroyuki;
    • Ito, Ayumu;
    • Wakayama, Toshio;
    • Matsuoka, Ken‐ichi;
    • Fukuda, Takahiro;
    • Tanaka, Junji;
    • Atsuta, Yoshiko;
    • Nakasone, Hideki
    Publication type:
    Article
    17

    Impact of Trial Eligibility Criteria on Outcomes of 1183 Patients With Follicular Lymphoma Treated in the Real‐World Setting.

    Published in:
    European Journal of Haematology, 2025, v. 114, n. 5, p. 832, doi. 10.1111/ejh.14373
    By:
    • Bennedsen, Tine Litske;
    • Simonsen, Mikkel Runason;
    • Jensen, Paw;
    • Brown, Peter;
    • Josefsson, Pär;
    • Khurana, Arushi;
    • Maurer, Matthew;
    • Clausen, Michael Roost;
    • Dessau‐Arp, Andriette;
    • Jørgensen, Jennifer Bøgh;
    • Jørgensen, Judit;
    • Larsen, Thomas Stauffer;
    • Pedersen, Lars Møller;
    • Jakobsen, Lasse Hjort;
    • El‐Galaly, Tarec Christoffer
    Publication type:
    Article
    18

    Treatment‐Free Remission Outcomes in a BCR::ABL1 Digital PCR Selected Clinical Cohort of CML Patients.

    Published in:
    European Journal of Haematology, 2025, v. 114, n. 5, p. 900, doi. 10.1111/ejh.14368
    By:
    • Kockerols, C.;
    • Valk, P. J. M.;
    • Hogenbirk, P.;
    • Geelen, I.;
    • Blijlevens, N. M. A.;
    • Janssen, J. J. W. M.;
    • Hoogendoorn, M.;
    • Kersting, S.;
    • Klein, S. K.;
    • Daenen, L. G. M.;
    • Donker, M.;
    • te Boekhorst, P. A. W.;
    • Jie, K.‐S. G.;
    • Corsten, M.;
    • Cruijsen, M. J.;
    • Levenga, H.;
    • Smit, W. M.;
    • Levin, M.‐D.;
    • de Jongh, E.;
    • de Jonge, S.
    Publication type:
    Article
    19

    Pomalidomide, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma: Final Survival and Subgroup Analyses From the OPTIMISMM Trial.

    Published in:
    European Journal of Haematology, 2025, v. 114, n. 5, p. 822, doi. 10.1111/ejh.14365
    By:
    • Richardson, Paul;
    • Beksaç, Meral;
    • Oriol, Albert;
    • Lindsay, Jindriska;
    • Schjesvold, Fredrik;
    • Galli, Monica;
    • Yağcı, Münci;
    • Larocca, Alessandra;
    • Weisel, Katja;
    • Yu, Xin;
    • Donahue, Cynthia;
    • Acosta, Jorge;
    • Peluso, Teresa;
    • Dimopoulos, Meletios
    Publication type:
    Article
    20

    The Role of Lifestyle and Environmental Factors in the Pathogenesis of Multiple Myeloma.

    Published in:
    European Journal of Haematology, 2025, v. 114, n. 5, p. 812, doi. 10.1111/ejh.14356
    By:
    • Suska, Anna;
    • Tyczyńska, Agata;
    • Zaucha, Jan Maciej;
    • Kopińska, Anna;
    • Helbig, Grzegorz;
    • Markiewicz, Mirosław;
    • Warzybok, Katarzyna;
    • Leder, Ewa;
    • Grosicki, Sebastian;
    • Machaliński, Bogusław;
    • Baumert, Bartłomiej;
    • Bator, Michał;
    • Usnarska‐Zubkiewicz, Lidia;
    • Fornagiel, Szymon;
    • Ciepłuch, Hanna;
    • Waszczuk‐Gajda, Anna;
    • Kruczkowska‐Tarantowicz, Kamila;
    • Rzepecki, Piotr;
    • Hus, Marek;
    • Morawska‐Krekora, Anna
    Publication type:
    Article
    21

    Issue Information.

    Published in:
    European Journal of Haematology, 2025, v. 114, n. 5, p. 707, doi. 10.1111/ejh.14235
    Publication type:
    Article